Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Pyxis Oncology, Inc. before investing. In this article, we go over a few key ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Get the latest Plus Therapeutics, Inc. (PSTV) stock news and headlines to help you in your trading and investing decisions.